Detalhe da pesquisa
1.
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
N Engl J Med
; 389(14): 1263-1272, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792612
2.
Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series.
J Rheumatol
; 51(4): 390-395, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38224979
3.
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission.
Ann Rheum Dis
; 82(2): 253-261, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973802
4.
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.
Ann Rheum Dis
; 82(7): 937-944, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958796
5.
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial.
Rheumatology (Oxford)
; 62(5): 1870-1876, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111858
6.
B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With Rituximab.
J Rheumatol
; 50(3): 420-425, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521910
7.
Prevalence of frailty in patients with polymyalgia rheumatica and association with health-related quality of life, cognition and sarcopenia.
Rheumatology (Oxford)
; 61(11): 4455-4464, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35136992
8.
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension.
Rheumatology (Oxford)
; 61(7): 2915-2922, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718434
9.
A genomic meta-analysis of clinical variables and their association with intrinsic molecular subsets in systemic sclerosis.
Rheumatology (Oxford)
; 62(1): 19-28, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751592
10.
Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement.
Ann Rheum Dis
; 80(2): 228-237, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028580
11.
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale.
Clin Exp Rheumatol
; 39 Suppl 131(4): 124-133, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34323681
12.
Trial of Tocilizumab in Giant-Cell Arteritis.
N Engl J Med
; 377(4): 317-328, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28745999
13.
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis.
Ann Rheum Dis
; 79(9): 1243-1249, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32581088
14.
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.
J Autoimmun
; 105: 102302, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31320177
15.
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.
Am J Hum Genet
; 96(4): 565-80, 2015 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25817017
16.
Response to: 'Correspondence on 'Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement'' by Manetti.
Ann Rheum Dis
; 82(1): e22, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33158883
17.
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.
Rheumatology (Oxford)
; 57(4): 639-650, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29340623
18.
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts.
Rheumatology (Oxford)
; 57(9): 1623-1631, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29868924
19.
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial.
Clin Exp Rheumatol
; 36 Suppl 113(4): 146-149, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30277862
20.
Current therapies for ANCA-associated vasculitis.
Annu Rev Med
; 66: 227-40, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341007